Late-toxicity burden high among survivors of high-risk neuroblastoma
CHICAGO — Survivors of high-risk neuroblastoma face a substantial burden of late toxicity, according to study results presented at ASCO Annual Meeting.Prevalence of some late effects vary by treatment received, findings showed.
Source: healio.com